1.4.3.1 Industry-academia: Research as service

From EQIPD
Revision as of 13:32, 17 March 2021 by Antonbespalov (talk | contribs) (Created page with "=Background and Expectations= A significant percentage of drug discovery and development efforts is outsourced to external service providers. Biopharmaceutical industry aims...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

Background and Expectations

A significant percentage of drug discovery and development efforts is outsourced to external service providers. Biopharmaceutical industry aims to achieve the same robustness and reliability of research data whether originating from internal laboratories or external collaboration partners.

With this objective in mind, EQIPD has developed experimental record-keeping guidelines for organizations performing non-regulated research under contractual agreement conditions. The practices outlined are intended to safeguard data traceability and data integrity, to facilitate decision making and create reliable scientific evidence to bring the best possible solutions to patients.

Further, EQIPD has developed a tool that allows assessment of research practices at organizations conducting research as a service (e.g., contract research organizations). This tool is used by sponsors of research to quality service providers prior to concluding the legal contracting paperwork.

The tool may also be used by both sponsors and service providers to trigger a more in-depth assessment of research practices by the EQIPD team.


Resources

EQIPD experimental record-keeping guidelines

Service provider assessment tool